GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clinica Baviera SA (XMAD:CBAV) » Definitions » YoY EBITDA Growth

Clinica Baviera (XMAD:CBAV) YoY EBITDA Growth : 8.49% (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Clinica Baviera YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Clinica Baviera's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 8.49%.

Clinica Baviera's EBITDA per Share for the three months ended in Mar. 2024 was €1.32.


Clinica Baviera YoY EBITDA Growth Historical Data

The historical data trend for Clinica Baviera's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinica Baviera YoY EBITDA Growth Chart

Clinica Baviera Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.16 8.41 55.99 4.94 19.79

Clinica Baviera Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.31 15.95 13.54 52.34 8.49

Clinica Baviera YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Clinica Baviera's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(4.122-3.441)/ | 3.441 |
=19.79 %

Clinica Baviera's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(1.316-1.213)/ | 1.213 |
=8.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clinica Baviera YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Clinica Baviera's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Clinica Baviera (XMAD:CBAV) Business Description

Traded in Other Exchanges
Address
Paseo de la Castellana 20, Madrid, ESP, 28046
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.

Clinica Baviera (XMAD:CBAV) Headlines

No Headlines